Navigation Links
China Recombinant Protein Drug Industry Report, 2014-2017
Date:11/22/2014

DUBLIN, Nov. 21, 2014 /PRNewswire/ --Research and Markets has announced the addition of the "China Recombinant Protein Drug Industry Report, 2014-2017" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014.

The start of recombinant protein drugs in China is not late and common drugs are diversified in variety, for example, recombinant human erythropoietin (rhEPO), recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human interferon (rhIFN) have gained market approval in the 1990s. Moreover, in 2013, domestic rhG-CSF, rhEPO andrecombinant human growth hormone (rhGH) with price advantage took a respective share of 82.1%, 88.5% and 90.2% in Chinese sample hospitals, and recombinant human interleukin-2/11(rhIL-2/11) was fully localized.

However, as compared with products from leading bio-pharmaceutical enterprises in the United States and Europe, domestic recombinant protein drugs are still characterized by low-end technologies and largely remain in common short-acting areas. And foreign brands still prevail in the markets of recombinant insulin, rhIFN, recombinant coagulation factor and recombinant human follicle-stimulating hormone (rhFSH).

1. Recombinant Insulin Market. In 2013,foreign brands such asNovo Nordisk's insulin aspart and insulin detemir, Sanofi's insulin glargine, Eli Lilly's insulin lispro accounted for 91.4% of recombinant insulin market of Chinese sample hospitals, while domestic insulin e.g. insulin glargine and insulin lispro of Gan & Lee Pharmaceuticals, recombinant insulin of Tonghua Dongbao Pharmaceuticaland animal insulin of Wanbang Biopharmaceuticalswas at a distinct disadvantage, whereas insulin analog products of Gan & Lee are still in the process of development, with huge potential for growth in the future.

2. rhIFN-aMarket.Roche's PEG-IFNa-2a, MSD's PEG-IFNa-2a and IFN-a-2a, and other imported products still dominate Chinese interferon market, sweeping as much as 70.7% of recombinant interferon market of sample hospitals in 2013; whilemore than a dozen local companies like Shanghai Huaxin High Biotechnology Inc., Beijing Tri-Prime Genetic Engineering Co., Ltd. and Anhui Anke Biotechnology (Group) Co., Ltd.mainly produce ordinary short-acting products, which lack strong competitiveness compared with PEG-Intron products (long-acting interferon)with better anti-hepatitisvirus effect.

Moreover, there is no domestic recombinant protein drug in such markets as rhIFN-ß, rhFSH, recombinant coagulation factor VIIa and factorVIIIyet.

Based on support from favorable policies, R&D ability enhancement as well as being optimistic about market prospects, a large number of biotech companies are vigorously developing long-acting, high-end protein drugs.

Key Topics Covered:

1. Overview of Recombinant Protein Drug Industry

2. Development of Recombinant Protein Drugs in China

3. Recombinant Protein Drug Market Segments in China

4. Major Recombinant Protein Companies in China

5. Summary and Forecast

Companies Mentioned:

  • 3SBio Inc.
  • Anhui Anke Biotechnology (Group) Co., Ltd.,
  • Beijing SL PHarmaceutical Co., Ltd.
  • Changchun High & New Technology Industry (Group) Inc.
  • Essex Bio-Technology Limited
  • Jiangsu Shihuan Bioengineering Co., Ltd.
  • Livzon Pharmaceutical Group Inc.
  • Shenzhen Neptunus Interlong Bio-Technique Co., Ltd.
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Uni-Bio Science Group Limited

For more information visit http://www.researchandmarkets.com/research/zs8mct/china_recombinant

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. CentraState and Freehold Radiology Group train physicians from China
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report
5. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
6. China Biologic Products Reports Higher Results for the First Quarter 2012
7. China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results
8. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
9. China Botanic Attends 67th PHARMCHINA Fair
10. Xiangxue Pharmaceuticals to Acquire Rights for a Promising Drug Candidate from Kinex Pharmaceuticals for the Greater China Territory
11. China Botanic Attends the 111th China Import and Export Fair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... 2020 , ... The Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, announced a partnership with VeloCity, a fundraising ride benefiting Grady Hospital, around the ... place on May 2nd and begins on the Mercedes-Benz Stadium field and ends at ...
(Date:2/16/2020)... ... February 16, 2020 , ... In Partnership with the Smiles for ... its Kennewick, WA office. , A limited number of appointments are available, but there ... more information or to schedule an appointment, please call (509)-820-4302. , Who: Bright Now! ...
(Date:2/14/2020)... ... February 14, 2020 , ... ... Science and Commerce beginning fall semester 2020, the first of its kind in ... interested in a career in the cannabis industry and will provide students with ...
Breaking Medicine Technology:
(Date:2/19/2020)... ... February 19, 2020 , ... Spaulding Youth Center is ... the Doug Flutie, Jr. Foundation for Autism. The grant will directly support Spaulding’s ... physical fitness program will include the hiring of a fitness professional who will ...
(Date:2/19/2020)... ... February 19, 2020 , ... Actor, ... he is most known for his acting abilities demonstrated in blockbuster hits like ... show “Behind The Scenes” with Laurence Fishburne. “Behind The Scenes” features a broad ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... and consistency of healthcare delivery, announced that it will participate in the ... Orlando, Florida. BPM+ Health will engage healthcare professionals and other stakeholders at HIMSS20 ...
(Date:2/19/2020)... ... 2020 , ... SafiraMD Medical Aesthetics & Wellness Center is ... most popular non-invasive fat reduction treatment. Their CoolEvent will be held on March ... Alpharetta, Georgia. The CoolEvent will feature live demonstrations, exclusive discounts, giveaways and much ...
(Date:2/15/2020)... ... February 14, 2020 , ... ... Baptist Easley Hospital , a member of Prisma Health, providing a comprehensive ... the world-class hospital was able to cut its monthly laundry management costs in ...
Breaking Medicine News(10 mins):